Faculty

Institution

Unit

Venue

Dzifa Duose

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Pathology And Translational Molecular Pathology

Dzifa Duose is a Senior Professor at The University of Texas MD Anderson Cancer Center. Her research integrates oncology, immunology, and molecular diagnostics, with a focus on tumor biology, pathology, and cancer immunotherapy. Recent work includes CSF ctDNA analysis for molecular reclassification of diffuse gliomas, immune microenvironment characterization in brain metastases, and a phase I/II trial of intratumoral sotigalimab with pembrolizumab in metastatic melanoma. She has also developed prognostic gene signatures for papillary thyroid carcinoma and multi-omics biomarker approaches for pancreatic cyst fluid evaluation. Her translational research spans radiation oncology, pharmacology, and medicinal research, advancing precision diagnostics and therapeutic strategies across multiple cancer types.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Dzifa Duose

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

oncology cancer research immunology pathology molecular diagnostics cancer immunotherapy tumor biology medicinal research radiation oncology cancer biology oncogenes medicine cancer care clinical research molecular cancer cellular therapy cancer treatment immunotherapy hematological malignancies cancer cells colorectal cancer thoracic oncology cancer genomics metastasis hematology cancer genetics leukemia immune checkpoint inhibitors cancer discovery tumor heterogeneity next-generation sequencing tumor targeting thyroid genitourinary cancers lymphoid neoplasia myeloid neoplasia surgical oncology pharmacotherapy cancer imaging histopathology therapeutic efficacy melanoma gastrointestinal oncology thyroid disease cancer management prognostic biomarkers anti-cancer agents tumor dna metastatic colorectal cancer genome biology tumoral pathology cytopathology molecular pathology oncogenic agent skin cancer clinical neurology pancreatic cancer anaplastic thyroid carcinoma myeloid malignancies endocrine oncology novel therapies malignant disease oncologic imaging sequence analysis targeted therapy phase ii trial solid tumors phase ii study haplotype analysis evolutionary action score immune microenvironment brain metastases immune evolution underlying molecular features lung adenocarcinomas mesonephric-like carcinoma

Notable Scholarly Works

Notable Federal Grants

Collaborators

Csf Ctdna Analysis Guides Molecular Reclassification of Diffuse Glioma Patients. Journal of Neuro-Oncology (2026)

neurologybrain pathologygliomasneuroimagingbrain tumor researchmolecular diagnosticsoncologyneuro-oncologytumor heterogeneitypathology

Intratumoral Sotigalimab With Pembrolizumab Induces Rapid Activation of Antigen Presenting Cells and Drives Anti-Tumor Responses in Non-Injected Tumors in Metastatic Melanoma: A Phase I/II Study. Cancer Discovery (2026)

immunologymetastasisintratumoral sotigalimabphase i/ii studyradiation oncologymolecular cancerimmune checkpoint inhibitorscancer immunosurveillancemetastatic melanomacancer immunotherapyimmunoeditingmedicinal researchcellular therapyimmunotherapy

Ionizing Radiation Enhances Prognostically Significant Cellular Immunity Programs in the Brain Metastasis Microenvironment. Clinical Cancer Research (2026)

immunologyradiation effectsmetastasisbrain metastasis microenvironmentradiation oncologybrain tumor researchradiation biologycancer immunotherapycancer cellstumor microenvironmentradiationradiation therapycellular therapybrain-immune interaction

PRECISE: A Prognostic Thyrocyte-Derived Gene Signature for Papillary Thyroid Carcinoma. Clinical Cancer Research (2026)

carcinogenesiscancer geneticscancer researchthyroidgeneticspapillary thyroid carcinomacancer letterpathologythyroid disease

12. Analytical Validation and Cross-Platform Analysis of the Oncomine Tcr Pan-Clonality Assay for T-Cell Receptor Profiling. Cancer Genetics (2025)

immunologyimmunological biomarkerst-cell receptor profilingcellular immune responsesimmunologic mechanismscell researchcancer immunotherapymolecular diagnosticsimmune responsescross-platform analysispathologyanalytical validationimmunotherapycell biology

82. Development and Validation of a Liquid Biopsy Next Generation Sequencing Assay for Hpv Detection Cancer Patients. Cancer Genetics (2025)

medical virologycancer researchviral diagnosticsvirologymolecular diagnosticsoncologycancer-associated virusinfectious diseasespathologycancer detectiondiagnostic virology

Abcl-698: Evaluation of Gene Expression Assays to Classify Large B-Cell Lymphoma by Molecular Subtype From Formalin-Fixed, Paraffin-Embedded Tumor Biopsy Tissue (Ffpet). Clinical Lymphoma Myeloma & Leukemia (2025)

immunologyhematological malignanciesmolecular subtypecancer researchlymphoid neoplasiacancer discoverymolecular pathologymolecular diagnosticsoncologygene expression assayslarge b-cell lymphomapathologytumor biologycell biology

Abstract 3776: Association of Baseline Ctdna Egfr Mutation Detection With Clinical Outcome in the Phase II Ramose Trial Assessing Ramucirumab Plus Osimertinib Versus Osimertinib in Egfr Mutant Non-Small Cell Lung Cancer. Cancer Research (2025)

Simon HeekeDzifa DuoseSrividya ArjunaMonique NilssonJyoti PatelElaine ShumChristina BaikRachel SanbornCatherine ShuChul KimMary Jo FidlerRichard HallJhanelle GrayAndreas SaltosJohn V. HeymachXiuning Le

geneticsclinical trialsmolecular diagnosticsclinical researchgenetic testingclinical outcome

Abstract B098: A High-Throughput Rna-Based Screening Platform for Matching Patients to Antibody-Drug Conjugate Trials. Molecular Cancer Therapeutics (2025)

immunologyomicsbiomarkershigh-throughput screeningabstract b098systems biologymicroarray data analysiscancer discoveryantibody-drug conjugate trialsmolecular diagnosticsantibody screeningmolecular informatics

A Multi-Institutional Phase 1 Clinical Trial Exploring Upfront Multimodal Standard of Care and Combined Immunotherapies for Newly Diagnosed Glioblastoma. Neuro-Oncology (2025)

Patrick Y WenAndrea ManzaneraCaroline DuaultEdgar Gonzalez-KozlovaLenika LopezStuart A GrossmanXiaobu YeJoy FisherIan LeeTobias WalbertJames SnyderSteven BremArati DesaiStephen J BagleyChandana KakaniRoy StrowdStephen TatterAdrian LaxtonGlenn LesserNduka AmankulorFrank LiebermanJan DrappatzMegan ManticaDan TriggsCara HaymakerIgnacio I WistubaGheath al-AtrashJulia Mendoza PerezAndrew FutrealLatasha D LittleM D Habibul IslamDzifa DuosePeixin JiangAlexandre ReubenSean E LawlerMina PichavantAndrew GentlesSean BendallAlex KongChristine CamachoDiane Del ValleSeunghee Kim-SchulzeSacha GnjaticElad SharonM Oskar NowickiPierpaolo PeruzziDoug LaneEstuardo Aguilar-CordovaLaura K AguilarGarrett NicholsJessica DwyerPaul Peter TakHolden MaeckerFrancesca BaroneE Antonio Chiocca

upfront multimodal standardfamily medicineneuro-oncologycancer carecancer managementpalliative medicineclinical neurosurgeryneurosurgerysurgical oncologycancer immunotherapycancer treatmentimmunologyradiologyclinical implementationgliomasclinical trialsoncologyclinical neurologyexperimental medicine

1
2
3
4
5
10
10 / page

Dzifa Duose

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Pathology And Translational Molecular Pathology

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Dzifa Duose

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Csf Ctdna Analysis Guides Molecular Reclassification of Diffuse Glioma Patients. Journal of Neuro-Oncology (2026)

neurologybrain pathologygliomasneuroimagingbrain tumor researchmolecular diagnosticsoncologyneuro-oncologytumor heterogeneitypathology

Ionizing Radiation Enhances Prognostically Significant Cellular Immunity Programs in the Brain Metastasis Microenvironment. Clinical Cancer Research (2026)

PRECISE: A Prognostic Thyrocyte-Derived Gene Signature for Papillary Thyroid Carcinoma. Clinical Cancer Research (2026)

carcinogenesiscancer geneticscancer researchthyroidgeneticspapillary thyroid carcinomacancer letterpathologythyroid disease

12. Analytical Validation and Cross-Platform Analysis of the Oncomine Tcr Pan-Clonality Assay for T-Cell Receptor Profiling. Cancer Genetics (2025)

82. Development and Validation of a Liquid Biopsy Next Generation Sequencing Assay for Hpv Detection Cancer Patients. Cancer Genetics (2025)

medical virologycancer researchviral diagnosticsvirologymolecular diagnosticsoncologycancer-associated virusinfectious diseasespathologycancer detectiondiagnostic virology

geneticsclinical trialsmolecular diagnosticsclinical researchgenetic testingclinical outcome

Abstract B098: A High-Throughput Rna-Based Screening Platform for Matching Patients to Antibody-Drug Conjugate Trials. Molecular Cancer Therapeutics (2025)

A Multi-Institutional Phase 1 Clinical Trial Exploring Upfront Multimodal Standard of Care and Combined Immunotherapies for Newly Diagnosed Glioblastoma. Neuro-Oncology (2025)

1
2
3
4
5
10
10 / page